Human IGFBP-3 Antibody, R&D Systems™

IGFBP-3

Polyclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

acid stable subunit of the 140 K IGF complex, binding protein 29, binding protein 53, growth hormone-dependent binding protein, IBP-3, IBP3BP-53, IGF-binding protein 3, IGFBP3, IGFBP-3, insulin-like growth factor binding protein 3, insulin-like growth factor-binding protein 3

Goat

Affinity Purified

RUO

3486

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Western Blot, Immunohistochemistry, Neutralization

LYOPH

Western Blot 0.1 ug/mL, Immunohistochemistry 5-15 ug/mL, Neutralization 0.75-3.0 ug/mL

CAA46087

IGFBP3

Mouse myeloma cell line NS0-derived recombinant human IGFBP-3 Gly28-Lys291 Accession # CAA46087

25 μg

Primary

Detects human IGFBP-3 in direct ELISAs and Western blots. In direct ELISAs, approximately 10% cross reactivity with recombinant mouse IGFBP-3 is observed, and less than 1% cross-reactivity with recombinant human (rh) IGFBP-1, rhIGFBP-2, and rhIGFBP-4 is observed.

Human

IgG